Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.

Journal article

Tunn R. et al, (2024), J clin epidemiol

e-Lung CT Biomarker Stratifies Patients at Risk of IPF Progression in a 52-Week Clinical Trial.

Journal article

Devaraj A. et al, (2024), Am j respir crit care med

Load More